Dublin, May 24, 2018 (GLOBE NEWSWIRE) -- The "Imaging Agents - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Imaging Agents in US$ by the following Product Segments:
- Contrast Media (X-Ray/CT, MRI, & Ultrasound)
- Diagnostic Radiopharmaceuticals.
The report profiles 52 companies including many key and niche players such as:
- 3B Pharmaceuticals
- Advanced Accelerator Applications
- Aytu BioScience, Inc.
- Bayer Healthcare Pharmaceuticals
- Blue Earth Diagnostics
- Bracco Diagnostics, Inc.
- Bracco-Eisai Co., Ltd
- Cell>Point
- Curium
- Daiichi Sankyo Company Limited
- Eli Lilly and Company
- FluoroPharma
- GE Healthcare
- Ground Fluor Pharmaceuticals
- Guerbet Group
- HealthTrust
- IBA Molecular
- Ipsen
- Lantheus Medical Imaging, Inc.
- Mallinckrodt
- Novartis
- Oncardia
- Piramal Imaging SA
- SurgVision
- Vizient
Key Topics Covered:
1. INDUSTRY OVERVIEW Imaging Agents: Providing Brighter and Clearer Images for Effective Clinical Diagnosis Growing Need for Early Disease Diagnosis Fosters Demand for Imaging Agents Major Growth Drivers in a Nutshell Select Market Growth Restraints Contrast Media: Giving Way to Contemporary Offshoots X-ray/CT Segment Continues to Lead Contrast Media Market Developed Economies Face Threat from Rising Demand for Contrast Agents in Asia-Pacific Diagnostic Radiopharmaceuticals to Outdo Contrast Media Nuclear Medicine: A Potential Growth Avenue for Dx Radiopharmaceuticals Select PET and SPECT Radioisotopes Used in Nuclear Medicine Select Cardiology and Oncology Radiopharmaceuticals Developed Markets Rule the Imaging Agents Market, Developing Regions to Spearhead Future Growth 2. SEGMENTAL OVERVIEW AND COMPETITIVE LANDSCAPE Market Structure Key Market Participants Contrast Media Popular Brands of Contrast Agents X-ray Contrast Media MRI Contrast Media Market Scenario Key Players in the MRI Market List of FDA Approved Gadolinium-Based Contrast Agents (GBCA) for CNS MRI List of EMA Approved Gd Chelated Contrast Agents Controversies over GBCAs Refuse to Die Down A Comparison of Select Gadolinium-based Contrast Agents Select GBCA-Induced Toxicities Gadolinium Accumulation in Brain A Major Concern for the Market FDA Finds Concerns over Accumulation of Gadolinium Used in MRI Brain to be Unfounded FDA Issues Drug Safety Communication for Gadolinium-Based MRI Contrast Agents EMA Places Restrictions on Use of Linear Gadolinium Agents for Body Scans Competitive Re-arrangement Surfaces as Safety Concerns on GBCAs Reach their Peak Glucose Can it Replace GBCAs for MRIs? Ultrasound Contrast Media Limited System Use Curtails Demand for Ultrasound Contrast Agents, Potential for Further Growth Exists CEUS and Ultrasound Contrast Agents A Dichotomy in Approach in Europe and the US A Comparison of Approved Ultrasound Contrast Agents Approved Ultrasound Contrast Agents by Country and Application Contrast Media API Production Still Largely In-house A Peek into API Supplier Space for Select Contrast Media Diagnostic Radiopharmaceuticals Market Overview Commonly Used Diagnostic Radiopharmaceutical Agents Major Isotopes and their Diagnostic Applications Select FDA Approved Diagnostic Radiopharmaceuticals by Indication Prospects for Radiopharmaceutical Agents in PET and SPECT Appear Brighter 3. MARKET TRENDS & ISSUES Sustained Expansion of Molecular Imaging Platform Presents Positive Outlook Novel Radiopharmaceuticals Add New Dimensions to Molecular Imaging Latest Radiopharmaceuticals to Benefit Molecular Imaging Microbubbles/Ultrasound Contrast Agents Set for Strong Growth Growing Interest in Image Guided Surgery Offers New Opportunities Role of Near-Infrared Contrast Agents for Image Guided Surgery Fluorescence Optical Imaging Opens New Avenues Coronary CT Angiography Opens Up Opportunities for Contrast Agents List of Iodine-Containing Contrast Agents for Coronary CT Angiography Targeted Imaging A Game Changer in the Making Rising Clinical Acceptance of MRI Systems Augurs Well for Contrast Agents Market Researchers Develop Iron Oxide-based Contrast Agent for MRI Nanomaterials Taking the Center Stage New Nanoparticle Contrast Agents on the Horizon Show Promise Gadolinium Coated Nanoparticles A Promising Imaging Agent Growing Focus on Development of Gold Nanoparticles in X-Ray Imaging Imaging Agents Make a Welcome Impact in the Field of Alzheimer's Disease List of FDA Approved Alzheimer's Diagnostic Imaging Agents Contrast-Enhanced Tomosynthesis Expands Opportunities Hyperpolarized Gases as Contrast Agents Multi-Modal Imaging: Combating Contrast Medium Inconsistencies Falling Prices Turn on the Heat Ultrasound Contrast Agents in Diagnosis of Kidney Ailments PET: A Prime Growth Driver for Diagnostic Radiopharmaceuticals Innovative Radiotracers to Boost Cardiac Applications for SPECT and PET Modalities A Peek at Global CVD Stats Echocardiography Examinations Improving Diagnostic Quality through Contrast Agents Opportunities on Rise for Fluorine-Based Myocardial Perfusion Agents Unfounded Fears of Radiation Exposure: A Major Concern for Nuclear Diagnostics Rising Incidence of Cancer A Major Growth Driver World Cancer Statistics Incidence and Mortality Data Improving Healthcare Expenditure to Foster Growth Aging Population A Vital Demography A Peek into Pricing Dynamics Packaging of Contrast Agents An Overview Global Supply Shortages Restrains Radiopharmaceuticals Market Price Sensitivity & Competition from Alternatives Lack of Dosage Standards for Pediatric Patients Limits Radiopharmaceutical Efficacy Reimbursement Scenario Europe United States 4. GLOBAL MEDICAL IMAGING MARKET - AN OVERVIEW Medical Imaging Changing the Landscape of Clinical Diagnosis Key Trends in the Global Medical Imaging Market Growing Need for Medical Diagnostic Equipment, Outside Western World Healthcare Providers Seeking Newer Cost-Effective Methods Cost Related Issue of Electronic Technology Used for Diagnostic Purposes Upgradation of Existing Imaging Equipment Growing Prominence of 3D Technology in Medical Applications Archaic X-Ray Imaging Modalities Paving Way for Digital X-Rays Ultrasound Holds its Fort in the Medical Imaging Market Technological Advancements Favor MRI Market Nuclear Medicine Imaging Equipment Presents Lucrative Growth Opportunities Hybrid Imaging to Herald a New Era of Diagnosis Hybrid PET/MRI Systems: A New Fusion Unfounded Fears of Radiation Exposure Hinder Growth Bottlenecks in Developing Markets Use of Contrast Agents in Other Imaging Modalities Fluoroscopy Computed Tomography 5. PRODUCT OVERVIEW Contrast Agents Contrast Media: How Do They Function? Where Are They Used ? Evolution of Contrast Media: A Profile Bismuth Nitrate: Beginning of Contrast Agents Imaging Agents: Significant Developments in the Last Fifty Years Schering Develops First Intravenous Contrast Agent MRI: Creating a New Era for Contrast Agents A Peek into the Finer Points of Differences Among Contrast Media Second Generation Non-Ionic Contrast Agents: An Introduction Choice of the Contrast Medium: A Weighty Decision Factors Affecting choice of Imaging Agents Taxonomy Types of Contrast Media X-Ray Contrast Medium First Generation High Osmolar Contrast Media Second Generation Low Osmolar Contrast Media or LOCM MRI Contrast Medium Role of Contrast Enhancement in MR Angiography (MRA) MRI Contrast Agents for the Liver Paramagnetic Extracellular Contrast Agents Hepatobiliary Gadolinium Chelates Superparamagnetic Iron Oxide Particles Ultrasound Contrast Medium Ultrasonographic Contrast Media: What Are They? Ultrasound Contrast Enhancement in Cardiology Functionalities of Vascular Ultrasound Contrast Agents Diagnostic Radiopharmaceuticals A Delineate of Diagnostic Radiopharmaceuticals Diagnostic Radiopharmaceuticals: A Technical Run-Through Applications Classification Cardiology Diagnostics Non-cardiology Diagnostics Molecular Imaging Modalities in Radiopharmaceutical Diagnostics Planar Imaging Positron Emission Tomography (PET) Applications of PET Commonly used Radioisotopes in PET Scans Major PET Isotopes and their Applications Single Photon Emission Computed Tomography (SPECT) Applications of SPECT Commonly used Radioisotopes in SPECT Scans 6. TECHNOLOGY DYNAMICS Proprietary Technologies Making In-Roads Advanced Magnetics' Proprietary Colloidal Superparamagnetic Particle Technology Enzon's Single Chain Antigen-Binding Technology Immunomedics' Antibody Technology First Generation Second Generation Third Generation NeoRx's Painting the Target Technology Stage I Stage II Stage III Gas Encapsulation Technology for Ultrasound Contrast Media Pharmacyclics' Texaphyrin Technology Regulatory Bodies Entry Barriers Research Driven Markets Highly Competitive Market Economies of Scale Substitutes in Agents Manufacturing New X-ray Diagnostic Agents Amide-based Macrocyclic Ligands Potential MRI Agents Gadolinium (III) Complexes Potential MRI Contrast Agents Metal-Containing Compounds Act As Potential Contrast Agents Therapeutic Applications Diagnostic Applications Magnetic Gels as Potential MRI Contrast Agents PFCs as Diagnostic Contrast Agents Saline Flushes To Help Ensure Accurate Delivery of Contrast Agents 7. PRODUCT INNOVATIONS/INTRODUCTIONS/ APPROVALS NanoHybrids Introduces PAtrace Contrast Agent Ligand Commences Initiative to Develop New Captisol-Enabled Contrast Agents Guerbet Launches Contrast&Care GE Healthcare Launches Clariscan Gadolinium-based Contrast Agent Piramal Imaging Announces New Research on PET Imaging Tracers Bracco Bags FDA Approval for TAGITOL V for Use in Colon CT Imaging Guerbet Wins FDA Approval for Dotarem Use in MRI for Pediatric Patients for CNS Scanning Lantheus Begins Shipment of Xenon Xe 133 Gas Otsuka Launches ORALTAG in the US Advanced Accelerator Applications Receives FDA Approval for Netspot Blue Earth Diagnostics Secures FDA Approval for Axumin Bayer Obtains FDA Approval for Gadavist for MRA for Supra- aortic Arteries Bracco Secures FDA Clearance for LUMASON in Ultrasonography of the Liver for Lesion Characterization Bracco Obtains FDA Clearance for READI-CAT 2 and READI-CAT 2 SMOOTHIE NDA Bracco Bags FDA Approval for E-Z-HD for GI Tract Radiohraphic Exams 8. RECENT INDUSTRY ACTIVITY Novartis Acquires Advanced Accelerator Applications Bracco Imaging Takes Over SurgVision Mallinckrodt Divests Nuclear Imaging Business to IBA Molecular GE Healthcare Inks Agreement to Supply Radiopharmaceuticals to HealthTrust Cell>Point Inks Licensing Agreement with UEP for Oncardia FluoroPharma Inks Agreement to Take Over Ground Fluor Pharmaceuticals Bracco Diagnostics's LUMASON Obtains Innovative Technology Designation from Vizient Blue Earth Diagnostics Establishes Operations in the US Ipsen and 3B Pharmaceuticals Ink Licensing Deal for Oncology Radiopharmaceuticals Lantheus Divests Gludef Business in Canada to Isologic 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 52 (including Divisions/Subsidiaries 60)
- The United States (33)
- Canada (2)
- Japan (1)
- Europe (18)
- France (3)
- Germany (5)
- The United Kingdom (2)
- Italy (2)
- Rest of Europe (6)
- Asia-Pacific (Excluding Japan) (5)
- Africa (1)
For more information about this report visit https://www.researchandmarkets.com/research/q...aging?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Contrast Media
